Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and…
| Price | $88.49 |
|---|---|
| Market cap | $50.95B |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Exchange | NYSE |
| 52-week range | 72.3-96.29 |
| Beta | 0.85 |
Explore EW's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.